posted on 2013-03-05, 00:00authored byJohn A. Hangasky, Evren Saban, Michael J. Knapp
Oxygen homeostasis plays a critical
role in angiogenesis, erythropoiesis,
and cell metabolism. Oxygen homeostasis is set by the hypoxia inducible
factor-1α (HIF-1α) pathway, which is controlled by factor
inhibiting HIF-1α (FIH). FIH is a non-heme Fe(II), α-ketoglutarate
(αKG)-dependent dioxygenase that inhibits HIF-1α by hydroxylating
the C-terminal transactivation domain (CTAD) of HIF-1α at HIF-Asn803. A tight coupling between CTAD binding and O2 activation is essential for hypoxia sensing, making changes in the
coordination geometry of Fe(II) upon CTAD encounter a crucial feature
of this enzyme. Although the consensus chemical mechanism for FIH
proposes that CTAD binding triggers O2 activation by causing
the Fe(II) cofactor to release an aquo ligand, experimental evidence
of this has been absent. More broadly, this proposed coordination
change at Fe(II) has not been observed during steady-state turnover
in any αKG oxygenase to date. In this work, solvent isotope
effects (SIEs) were used as a direct mechanistic probe of substrate-triggered
aquo release in FIH, as inverse SIEs (SIE < 1) are signatures for
pre-equilibrium aquo release from metal ions. Our mechanistic studies
of FIH have revealed inverse solvent isotope effects in the steady-state
rate constants at limiting concentrations of CTAD or αKG [D2Okcat/KM(CTAD) = 0.40 ± 0.07, and D2Okcat/KM(αKG) = 0.32 ± 0.08], providing direct evidence of aquo release during
steady-state turnover. Furthermore, the SIE at saturating concentrations
of CTAD and αKG was inverse (D2Okcat = 0.51 ± 0.07), indicating that aquo
release occurs after CTAD binds. The inverse kinetic SIEs observed
in the steady state for FIH can be explained by a strong Fe–OH2 bond. The stable Fe–OH2 bond plays an important
part in FIH’s regulatory role over O2 homeostasis
in humans and points toward a strategy for tightly coupling O2 activation with CTAD hydroxylation that relies on substrate
triggering.